NCT06047626

Brief Summary

In this study the investigators are proposing to evaluate the efficacy, sustainability, and mechanisms of 3 months of individualized counseling of the FRD delivered by registered dietitians, over 8 sessions by phone/video conferencing on fatigue, quality of life, and associated symptoms in persistently fatigued lymphoma cancer survivors compared to 3 months of individualized counseling of the attention control (matched for time and frequency of interactions with the FRD) the General Health Curriculum (GHC). The investigators will randomize and follow 68 lymphoma cancer survivors; accounting for a \~10% drop out rate to achieve a target of 60 patients that will complete the study. The investigators hypothesize that persistently fatigued lymphoma cancer survivors will experience improvements in fatigue, quality of life, and symptoms commonly associated with fatigue, which are then maintained at 15-months post-enrollment; and decreased CRP and alterations in inflammation-associated DNA methylation consistent with reduced inflammation from following the FRD as compared to the GHC.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for not_applicable lymphoma

Timeline
29mo left

Started Mar 2024

Typical duration for not_applicable lymphoma

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress48%
Mar 2024Sep 2028

First Submitted

Initial submission to the registry

April 3, 2023

Completed
6 months until next milestone

First Posted

Study publicly available on registry

September 21, 2023

Completed
6 months until next milestone

Study Start

First participant enrolled

March 7, 2024

Completed
3.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2027

Expected
1 year until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2028

Last Updated

October 30, 2025

Status Verified

October 1, 2025

Enrollment Period

3.5 years

First QC Date

April 3, 2023

Last Update Submit

October 28, 2025

Conditions

Outcome Measures

Primary Outcomes (1)

  • Brief Fatigue Inventory

    To examine the effect of 3 months of FRD compared to an attention control GHC on persistent fatigue, measured with the Brief Fatigue Inventory. The instrument consists of 9 items, each measuring fatigue on a 0-10 scale, and is calculated from the mean of completed items

    3 months after enrollment

Secondary Outcomes (8)

  • Examining the effect of 3 months of FRD compared to an attention control GHC on Quality of life

    3 months after enrollment

  • The effect of 3 months of FRD compared to an attention control GHC on persistent sleep disturbance

    3 months after enrollment

  • The effect of 3 months of FRD compared to an attention control GHC on persistent pain

    3 months after enrollment

  • The effect of 3 months of FRD compared to an attention control GHC on persistent mood

    3 months after enrollment

  • The effect of 3 months of FRD compared to an attention control GHC on persistent sexual function

    3 months after enrollment

  • +3 more secondary outcomes

Study Arms (2)

Fatigue Reduction Diet- FRD

EXPERIMENTAL

3 months of individualized counseling of the FRD delivered by registered dietitians, over 8 sessions by phone/video conferencing on fatigue, quality of life, and associated symptoms in persistently fatigued lymphoma cancer survivors

Other: Fatigue Reduction Diet

General Health Curriculum- GHC

ACTIVE COMPARATOR

3 months of individualized counseling of the attention control (matched for time and frequency of interactions with the FRD) the General Health Curriculum (GHC)

Other: General Health Curriculum

Interventions

Sessions will be \~15 minutes for 8 sessions. The FRD maintains participants on a diet with their typical caloric intake as assessed at baseline, and replaces some of their calories with the following foods on a daily basis: at least 50% of servings grains to be whole grains (these would replace non-whole grain foods); 5 servings of vegetables (1 leafy green, 1 tomato, and 1 yellow/orange); 2 servings of fruit (1 high in vitamin C), both fruit and vegetables would replace some of the carbohydrates from non-fruit and vegetable sources; 1 serving of fatty fish and or 1 serving of nuts and/or seeds (2 servings of nuts and/or seeds for vegetarians), both the fish, the nuts, and seeds will replace existing sources of fats and proteins in the diet.

Fatigue Reduction Diet- FRD

These sessions will be matched counseling method, time spent (\~15 minutes per session), for 8 sessions. Registered Dietitians will discuss general health topics with the participant, excluding topics of diet and food.

General Health Curriculum- GHC

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Women and men aged 18 years and older
  • Diagnosis of lymphoma (Hodgkin and non-Hodgkin)
  • Have an average persistent fatigue defined as ≥ 4 on the Brief Fatigue Inventory
  • Fatigue must be attributed to lymphoma diagnosis
  • Fatigue onset must be between 12months before diagnosis and any time after diagnosis
  • Fatigue must not be attributed to other disease diagnoses
  • Fruit and vegetable intake ≤5.5 servings/day
  • Have, or be willing to create, an email address to receive study questionnaires electronically.

You may not qualify if:

  • Medically unstable
  • BMI\<18.5 kg/m2
  • Have a current untreated diagnosis of mood disorder, e.g., bipolar or major depressive disorder
  • Have a current untreated diagnosis of anemia
  • Have a current untreated diagnosis of hypothyroidism
  • Have an initiation, a cessation or change of treatment of any chronic medications, dietary supplements, behavioral therapy, physical therapy etc., or any planned change of medications, supplements, or therapies during the study
  • Have a current diagnoses of cachexia
  • Planning on becoming pregnant, currently pregnant or lactating

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Michigan

Ann Arbor, Michigan, 48109, United States

RECRUITING

MeSH Terms

Conditions

Lymphoma

Condition Hierarchy (Ancestors)

Neoplasms by Histologic TypeNeoplasmsLymphoproliferative DisordersLymphatic DiseasesHemic and Lymphatic DiseasesImmunoproliferative DisordersImmune System Diseases

Study Officials

  • Suzie Zick

    University of Michigan Rogel Cancer Center

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 3, 2023

First Posted

September 21, 2023

Study Start

March 7, 2024

Primary Completion (Estimated)

September 1, 2027

Study Completion (Estimated)

September 1, 2028

Last Updated

October 30, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

No we would not make individual data just composite data available.

Locations